logo CNEA


COMISION NACIONAL DE ENERGIA ATOMICA
Conocimiento de la energía nuclear para fines pacíficos
 
República Argentina 
Principal Organización Temas nucleares Ambito Educativo Como comunicarse con nosotros Buscador
 ¿Qué es la CNEA?
 Centros Atómicos
 Reactores
 Experimentales
 Oferta Tecnológica
 Bibliotecas
 IEDS
 Proyecto de Restitución
 Ambiental de la Minería
 del Uranio (PRAMU)
 Integración
 Latinoamericana
 Becas 2008
 Noticias de Abril
Calendario de eventos
 Cursos/Talleres
 Seminarios
 Congresos
 Meetings OIEA 2008
 Información a proveedores
 
Para conocer
 ¿Qué es la energía
 nuclear?
 Observatorio P. Auger
 Producción de Molibdeno
 con blancos de uranio
 al 20%
 BNCT: Español - English
 IBEROARSEN
 La Central Nuclear Atucha I
 opera con un núcleo de
 uranio levemente
 enriquecido
 Convención Conjunta:
 Español - English
 
Además
 Imágenes CNEA
 CNEA solidaria
 Arte y Ciencia
 Sitios de interés
 ARCAL
 Mapa del Sitio
 Web Interno
 Webmail
 CNEA --> BNCT --> Introduction  
 
Introduction

Boron Neutron Capture Therapy (BNCT) is a binary technique that involves the concurrent presence of a flux of neutrons of adequate energy and a 10B capture agent. Their interaction generates heavy particles that damage tumor cells. The neutron and boron components do not produce significant damage to tissues when they are present separately.

The following capture reaction occurs with a 94% incidence:

               10B + n ® 7Li + 4He + 2,31 MeV + g (478 KeV)
 

 The pathlength of 7Li and 4He (alpha particle) is approximately 5 m m and 8 m m respectively, i.e. approximately the diameter of a tumor cell (~ 10 m m).

A few alpha particles suffice to destroy a tumor cell. The destructive effect of the capture reaction would occur mainly in those cancer cells that have selectively accumulated boron. The normal cells that have not incorporated significant amounts of boron will not suffer significant damage.

The total dose deposited by BNCT results from the 10B capture reaction (large capture cross section), capture reactions with tissue hydrogen and nitrogen which produce gamma-rays and protons respectively, the gamma component of the beam, epithermal and fast neutrons. The nature and distribution of these dose components depend on the source of neutrons, the filters employed, the concentration and distribution of the boron compounds and the tissue composition.

This therapy is mainly being used for malignant brain tumors such as glioblastoma multiforme (GBM) and melanomas of different localizations. The technique is also beginning to be tested in other tumor types.


 Introduction
 Clinical Background
 BNCT Project at CNEA
 References
 Publications
 Symposium
 Presentations
 Sponsors